Biopharm News - BioPharm International

ADVERTISEMENT

Biopharm News
News from biopharmaceutical companies, including mergers, acquisitions, drug approvals, drug recalls.

Pfenex Awarded Anthrax Vaccine Contract

December 19, 2013

Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.

Nearly 400 Drugs in Development for Infectious Diseases

December 16, 2013

Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.

FDA Approves Extended-Release, Single-Entity Hydrocodone Product

October 28, 2013

Zhoydro ER is the first drug to have updated labeling now required for all ER/LA opioid analgesics.

Amarin Cuts Staff Following FDA Vote

October 23, 2013

Amarin cuts staff in half after an FDA committee rejects its product label expansion.

FDA Awards 15 Grants to Stimulate Drug, Device Development for Rare Diseases

October 22, 2013

FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.

Merck Cuts 8,500 Positions, Moves Headquarters

October 1, 2013

Merck announced plans to reduce its workforce by 8,500 and move its headquarters in order to sharpen its commercial and R&D focus.

Merck & Co. Receives Complete Response Letter From FDA Regarding Sugammadex Sodium Injection

September 27, 2013

Merck & Co. has received a Complete Response Letter from FDA for the resubmission of its new drug application for sugammadex sodium injection.

J&J's Janssen and PATH Partner to Develop Rilpivirine Formulation

September 27, 2013

J&J's Janssen and PATH partner to improve drug formulation that could help prevent HIV infection.

Cell Medica Opens Commercial Manufacturing Facility

September 26, 2013

Cell Medica, a T cell therapeutics company, has opened a European manufacturing facility in Berlin-Buch, Germany to develop, manufacture, and market treatments of infections and cancers related to oncogenic viruses.

ADVERTISEMENT

ADVERTISEMENT

Click here